1221P Outcomes of EGFR-mutant NSCLC patients with de novo brain metastases by upfront treatment

Autor:	W.L. Ng, T. Rajasekaran, K.W. Fong, Q.S. Ng, E-H. Tan, A. Thiagarajan, Sze Huey Tan, Kevin L.M. Chua, T.R. Siow, S.H.B. Chia, Daniel Shao-Weng Tan, W.D.T. Lim, A. Jain, M.-K. Ang, Y. Li, S.P. Yap, R. Kanesvaran, J. Ma, Wan-Ling Tan, G.G.Y. Lai
Rok vydání:	2021
Předmět:	Oncology business.industry Mutant Cancer research Medicine Hematology business
Zdroj:	Annals of Oncology. 32:S970
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::08321cf479a227349567ba37b832b757 https://doi.org/10.1016/j.annonc.2021.08.1826 Zobrazit plný text záznamu